Family Planning Associates Medical Group INC
Family Planning Associates Medical Group INC was paid $1.81M by Medicaid between Jan 2018 and Dec 2024, across 42 billing codes. Its largest line is S0199, Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs — 25% of everything it billed.
FRESNO, CA 93701
Next to other Obstetrics & Gynecology Physician providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,059 | $143K | |
| 2019 | 6,576 | $122K | |
| 2020 | 6,431 | $149K | |
| 2021 | 9,769 | $273K | |
| 2022 | 12,942 | $364K | |
| 2023 | 14,130 | $425K | |
| 2024incomplete | 14,321 | $337K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 25% | 5,218 | 5,139 | $460K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 14% | 10,676 | 10,039 | $254K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 14% | 548 | 541 | $253K |
| S4993 | Contraceptive pills for birth control | 7.9% | 1,839 | 1,809 | $144K |
| J3490 | Unclassified drugs | 6.9% | 9,467 | 8,320 | $125K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 5.3% | 2,842 | 2,821 | $96K |
| 58300 | 4.0% | 1,407 | 715 | $72K | |
| 90651 | 3.7% | 696 | 690 | $66K | |
| 59840 | 3.1% | 2,156 | 1,133 | $56K | |
| 11981 | 2.8% | 557 | 551 | $51K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 2.8% | 75 | 74 | $50K |
| A4267 | Contraceptive supply, condom, male, each | 2.6% | 10,223 | 9,975 | $47K |
30 more codes
| S0190 | Mifepristone, oral, 200 mg | 2.3% | 3,792 | $41K |
| G9920 | Screening performed and negative | 1.7% | 4,226 | $31K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 2,454 | $17K |
| 11976 | <1% | 370 | $11K | |
| 99152 | <1% | 1,096 | $8K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 965 | $7K |
| 99201 | <1% | 312 | $4K | |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 431 | $4K |
| 58301 | <1% | 235 | $3K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 1,735 | $3K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 160 | $2K |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 4,184 | $2K |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 665 | $2K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 72 | $1K |
| T1014 | Telehealth transmission, per minute, professional services bill separately | <1% | 432 | $877.89 |
| 85018 | <1% | 1,074 | $757.96 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 301 | $610.28 |
| 01966 | <1% | 34 | $310.50 | |
| 11982 | <1% | 26 | $243.86 | |
| 76998 | <1% | 13 | $233.10 | |
| 76830 | Ultrasound, transvaginal | <1% | 14 | $202.27 |
| 83986 | <1% | 110 | $76.90 | |
| 81025 | <1% | 201 | $72.80 | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 73 | $64.56 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 15 | $57.20 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 161 | $0.00 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 166 | $0.00 |
| 88142 | 0% | 13 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 163 | $0.00 |
| 87806 | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.